Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Clinical trial NCT03108495 · TERMINATED
Trial details
- NCT number
- NCT03108495
- Sponsor
- Iovance Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2025-08-22
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.